Study to Evaluate the Efficacy & Safety of P-3074 Topical Solution in

Updated 04/23/2024

Status Completed

Clinical Trial Summary

The purpose of this study is to confirm the clinical efficacy and the safety of P-3074 in participants with androgenetic alopecia.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03004469
Study type	Interventional
Source	Polichem S.A.
Contact
Status	Completed
Phase	Phase 3
Start date	August 2, 2016
Completion date	March 5, 2018

See also
	Status	Clinical Trial	Phase
	Completed	`NCT01189279` - Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia	Phase 1
	Completed	`NCT05296863` - Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia	Phase 3
	Completed	`NCT02503852` - STYLE -- A Trial of Cell Enriched Adipose For Androgenetic Alopecia	N/A
	Completed	`NCT05802173` - Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia	Phase 2
	Not yet recruiting	`NCT03154528` - Role of Vitamin D in Androgenetic Alopecia
	Terminated	`NCT02676310` - Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA)	Phase 1
	Recruiting	`NCT05910450` - A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss	Phase 3
	Completed	`NCT01325337` - Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia	Phase 2
	Not yet recruiting	`NCT02316418` - Hairstetics™ Anchoring System in Female Pattern Hair Loss (HAS-FPHL)	N/A
	Recruiting	`NCT06263413` - Clinical Workflow Optimization Using Artificial Intelligence for Dermatological Conditions
	Recruiting	`NCT05681897` - Comparing Platelet-Rich Plasma (PRP) Centrifugation Methods on Thrombocyte Concentration and Clinical Improvement of Androgenetic Alopecia	N/A
	Completed	`NCT05244980` - A Study of TDM-105795 in Male Subjects With Androgenetic Alopecia (AGA)	Phase 1
	Completed	`NCT01904721` - A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA)	Phase 2
	Recruiting	`NCT05914805` - A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2)	Phase 3
	Completed	`NCT04913519` - A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA)	Phase 1